Interferon alfa-2b

From WikiMD's Medical Encyclopedia

(Redirected from Interferon alpha-2b)

Type of medication


Interferon alfa-2b
File:1RH2 Recombinant Human Interferon-Alpha 2b-02.png
INN
Drug class
Routes of administration Intramuscular, subcutaneous, intravenous
Pregnancy category
Bioavailability
Metabolism
Elimination half-life 2-3 hours
Excretion Renal
Legal status
CAS Number 99210-65-8
PubChem 135346
DrugBank DB00011
ChemSpider
KEGG D00743


Interferon alfa-2b is a recombinant protein used in the treatment of various viral infections and cancer. It is a type of interferon, which are proteins made and released by host cells in response to the presence of pathogens such as viruses, bacteria, parasites, and tumor cells. Interferon alfa-2b is produced using recombinant DNA technology and is marketed under the brand name Intron A.

Medical uses[edit]

Interferon alfa-2b is used to treat a variety of conditions, including:

Mechanism of action[edit]

Interferon alfa-2b works by binding to specific receptors on the surface of cells, initiating a complex signaling pathway that leads to the expression of numerous genes. These genes are involved in:

  • Inhibiting viral replication
  • Enhancing the immune response
  • Inhibiting cell proliferation
  • Inducing apoptosis (programmed cell death)

Administration[edit]

Interferon alfa-2b can be administered via several routes, including:

Side effects[edit]

Common side effects of interferon alfa-2b include:

History[edit]

Interferon alfa-2b was one of the first recombinant proteins to be approved for medical use. It was developed in the 1980s and has since been used to treat millions of patients worldwide.

See also[edit]

Related pages[edit]


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.